Randomized, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-816336 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2011
At a glance
- Drugs BMS 816336 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 01 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 04 Dec 2009 Planned number of patients changed from 75 to 40 as reported by ClinicalTrials.gov.